This latest research on non-dystrophic myotonia offers promising results for those affected by the condition. Published in ...

Lamotrigine, a drug commonly used to treat epilepsy and certain mood disorders, has been shown to be an excellent treatment option for a rare genetic neuromuscular disease known as non-dystrophic ...

The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with ...

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

The Missouri legislature’s Task Force on Substance Abuse Prevention and Treatment convened at the State Capitol Thursday to ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

In addition to increased treatment costs, patients with head and neck cancers also experienced therapy changes during the ...

Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell ...

The Clearfield County Commissioners voted to cancel its contract with Mesach Recovery Services of Philipsburg to administer the medically assisted drug treatment program at the Clearfield County Jail ...

Although ibogaine gained popularity in the U.S. and Europe in the 1980s as a non-addictive treatment for drug dependency, it’s still classified as a Schedule I substance under the Controlled ...

The Board of Selectmen may soon ask voters to authorize the purchase of 2 Old Point Ave., the former Taylor’s Drug Store in ...

Buprenorphine is relatively safe and reduces the risk of opioid death by 38% compared with those not receiving medication.